Document Detail


Ethnicity and rectal cancer management in New Zealand.
MedLine Citation:
PMID:  24162629     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
AIM: Research shows survival disparities between Maori and non-Maori colon cancer patients, with comorbidity and cancer care being major contributing factors. We studied rectal cancer management and survival in a cohort of Maori and non-Maori patients with a newly diagnosed rectal cancer.
METHODS: 194 Maori and non-Maori patients diagnosed with rectal cancer between 2006 and 2008 were identified from the New Zealand Cancer Registry. Medical records were reviewed and patients compared on presentation, patient and tumour characteristics, and receipt and timing of treatment. Cox regression models were fitted to compare cancer-specific survival.
RESULTS: Compared to non-Maori patients, Maori patients were younger (mean age at diagnosis 63.5 and 69.2 for Maori and Non-Maori respectively; p<0.001) and had higher prevalence of comorbidity. Stage, grade and tumour size distributions were similar. Almost all stage I-III patients (97%) underwent definitive surgery, with no difference between Maori and non-Maori. Maori patients waited longer for referral to medical oncologists (40 days vs. 33 days; p=0.03). Results suggested Maori patients with stage IV disease may be less likely than non-Maori to be referred to palliative care (13% vs. 40%; p=0.07). The hazard ratio for cancer-specific death for Maori compared with non-Maori patients was 1.24 (95% CI 0.65-2.35).
CONCLUSION: The findings suggest both similarities and some differences in treatment and outcomes between Maori and non-Maori rectal cancer patients, but firm conclusions are limited by small sample size.
Authors:
Esther M Swart; Diana Sarfati; Ruth Cunningham; Elizabeth Dennett; Virginia Signal; Jason Gurney; James Stanley
Related Documents :
21368659 - Long-term remission of an advanced recurrent endometrial cancer in a heavily pretreated...
20700989 - Clinical applications of molecular biomarkers in prostate cancer detection.
22232209 - Oncogenic kras is required for both the initiation and maintenance of pancreatic cancer...
21686109 - Endoscope-assisted brachytherapy for pancreatic cancer: from tumor killing to pain reli...
21378329 - Expression of cancer stem cell markers cd133 and cd44 in locoregional recurrence of rec...
23716149 - The practice of nondisclosure of advanced cancer diagnosis in singapore: a continuing c...
21801279 - Role of notch signaling in colon homeostasis and carcinogenesis.
24986099 - Overview of a chemoresponse assay in ovarian cancer.
24089439 - New strategies in endometrial cancer: targeting the pi3k/mtor pathway--the devil is in ...
Publication Detail:
Type:  Journal Article     Date:  2013-10-18
Journal Detail:
Title:  The New Zealand medical journal     Volume:  126     ISSN:  1175-8716     ISO Abbreviation:  N. Z. Med. J.     Publication Date:  2013  
Date Detail:
Created Date:  2013-10-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0401067     Medline TA:  N Z Med J     Country:  New Zealand    
Other Details:
Languages:  eng     Pagination:  42-52     Citation Subset:  IM    
Affiliation:
Department of Public Health, University of Otago, Wellington, PO Box 7343 Wellington South, New Zealand. diana.sarfati@otago.ac.nz.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Variation in the use of medicines by ethnicity during 2006/07 in New Zealand: a preliminary analysis...
Next Document:  Maori nurses and smoking: what do we know?